Navigation Links
Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy

major phase III trials conducted at several centres. However, it is extremely important to establish in advance which of the treatments currently in use should be tested in such large-scale and expensive trials. Our impressive findings on docetaxel provide clear data for making this decision.²

Original publication: A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients with Androgen Independent Prostate Cancer. J. Urol., DOI:10-1016/j.juro.2007.01.148 Available to download at: www.jurology.com/article/PIIS0022534707002868/abstract Scientific contact: Prof. Michael Krainer Medical University of Vienna 1090 Vienna, Austria T +43 / 664 / 183 76 77 E michael.krainer@meduniwien.ac.at

Copy Editing and Distribution: PR&D - Public Relations for Research & Development Campus Vienna Biocenter 2 1030 Vienna, Austria T +43 / 1 / 505 70 44 E contact@prd.at

Michaela Fritsch Assistentin

PR&D - Public Relations for Research & Development

T +43 1 505 70 44 F +43 1 505 50 83 E fritsch@prd.at

Campus Vienna Biocenter 2 A 1030 Vienna, Austria


'"/>




Page: 1 2 3

Related medicine technology :

1. Protox Announces Positive Clinical Data from Prostate Cancer Study
2. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
5. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
6. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
7. Quest PharmaTechs Prostate Cancer Program Update
8. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
9. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
10. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
11. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
Post Your Comments:
(Date:7/6/2015)... , July 6, 2015  Student-athletes at community ... benefit from a recently established partnership between ImPACT ... California . The partnership enables member institutions ... distribute ImPACT ® concussion baseline and post-injury ... majority of community colleges in California ...
(Date:7/6/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Cantor ... The public is welcome to participate in the ... website. Event: Cantor Fitzgerald 2015 Healthcare ConferencePresenter:Ron Squarer, Chief ... Webcast: www.arraybiopharma.com About Array BioPharma Array BioPharma ...
(Date:7/6/2015)... ST. PAUL, Minn. , July 6, 2015 /PRNewswire/ ... manufacturer of devices that use neuroblocking technology to treat ... termination of the underwriting agreement and cancellation of its ... a price to the public of $0.87 per unit. ... book-running manager and Craig-Hallum Capital Group was acting as ...
Breaking Medicine Technology:California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 2California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 3EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ), a ... results for the quarter ended September 30, 2009. Revenues ... was $1.6 million, or $(0.06) per diluted share, for the ... pleased with our orders and contract awards, the third quarter ...
... Inc. (NYSE: ZMH ; SIX: ZMH) announced today that ... unsecured notes in an underwritten public offering consisting of $500.0 ... 5.75% notes due 2039. The 10-year notes were priced to ... 30-year notes were priced at 135 basis points above their ...
Cached Medicine Technology:EF Johnson Technologies Announces Third Quarter Results 2EF Johnson Technologies Announces Third Quarter Results 3EF Johnson Technologies Announces Third Quarter Results 4EF Johnson Technologies Announces Third Quarter Results 5EF Johnson Technologies Announces Third Quarter Results 6EF Johnson Technologies Announces Third Quarter Results 7EF Johnson Technologies Announces Third Quarter Results 8Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
(Date:7/6/2015)... ... 06, 2015 , ... For over twenty years, Doctors on Liens ... Throughout the company’s history the goal has been to be a comprehensive network of ... And while Doctors on Liens has certainly achieved that goal, the addition of ...
(Date:7/6/2015)... ... 07, 2015 , ... Currently, mobile testing is one the ... in the molecular diagnostic technologies, wide availability of immunosuppressive drugs and bioterrorism threats ... genetic engineering also open lucrative opportunities for the market players. , However, there ...
(Date:7/6/2015)... Yorba Linda, CA (PRWEB) , ... July 06, ... ... human biology into the pre-clinical stages of drug discovery. iPSCs are generated from ... potential to differentiate into any cell type in the human body. , ...
(Date:7/6/2015)... ... ... Respected southern California personal injury attorney Fernando D. Vargas has been honored ... has sharp legal skills as well as a superior commitment to client service. , ... a Top 10 Award from The National Academy of Personal Injury Attorneys (NAOPIA). , ...
(Date:7/6/2015)... ... July 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) ... chemicals and impurities; it also properly mineralizes the water with electrolyte salts.  Common ... These harmful contaminants are a byproduct of how the water is treated chemically.  ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2
... older adults, already shown to improve health, can also cut ... the University of Washington. The study appears in the February ... depression affects about 3 million older adults in the United ... health-care expenses, mostly due to an increased use of medical, ...
... Regional,Foodbank, which distributes millions of pounds of food to ... more than 30,000 pounds of meat,to help feed local ... America tour, an initiative led by celebrity cook,Paula Deen., ... servings of meat to the,nation,s hungry families, including those ...
... Feb. 6 Worrell Inc., a full-service,product design ... the Montreal and San Diego offices of Gad ... prowess with the,engineering proficiencies of Gad Shaanan Design., ... Worrell Inc.,-- International Kai Worrell. "We know how ...
... Presented at 15th Conference on ... Opportunistic Infections (CROI), BOSTON, Feb. 6 Schering-Plough ... of a Phase II clinical study,showed vicriviroc, its investigational ... weeks of therapy in treatment-,experienced HIV-infected patients, when administered ...
... (February 6, 2008)Perhaps the only positive spin one can put ... Other than that, the news is bad. It is nearly ... of their lives, and the limited treatment options have changed ... are determined to find new ways treat this poorly understood ...
... for Health Solutions study outlines plan to help,primary ... WASHINGTON, Feb. 6 Primary care physicians,should ... diseases,and be compensated accordingly for their enhanced role ... Deloitte Center for Health Solutions,( http://www.deloitte.com/centerforhealthsolutions ) concludes., ...
Cached Medicine News:Health News:Team treatment for depression cuts medical costs 2Health News:Team treatment for depression cuts medical costs 3Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 2Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 2Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 4Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 2Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 3
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
The best value and features offered in a complete EMR and Practice Management Solution...
... Department has worked extensively with practicing urologists ... and exam templates for the most commonly ... the most flexible electronic medical record systems ... to take the templates we have provided ...
... CellaVision DM96 is an Automated Digital Cell ... pre-classification/characterization, display, storage and transmission of White ... 96 stained peripheral blood smears can be ... from 30 60 per hour depending ...
Medicine Products: